Biopharmaceutical Companies

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company that focuses on therapies for Alzheimer's Disease, were trading higher by more than 5 percent Thursday morning - only to give up gains and trade flat by the afternoon. Investors and traders were...

Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) were trading lower by more than 65 percent early Monday morning after the company reported disappointing results from a clinical trial. BioCryst designs, optimizes and develops novel small molecule drugs that block key enzymes involved in...

Shares of Fate Therapeutics Inc (NASDAQ: FATE), a clinical-stage biopharmaceutical company engaged in the development of programmed cellular therapeutics, were trading lower by 5 percent at $2.37. Fate Therapeutics' stock was trading higher by more than 16 percent in the pre-market trading session...